港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

銀諾醫藥－Ｂ

51.300

-1.300-2.47%

成交量：41.66萬

成交額：2,131.29萬

市值：234.35億

市盈率：-112.93

高：51.700

開：51.500

低：50.750

收：52.600

52周最高：74.000

52周最低：49.500

股本：4.57億

香港流通股本：4.20億

量比：0.72

換手率：0.10%

股息：- -

股息率：- -

每股收益(LYR):-0.454

淨資產收益率：-23.27%

總資產收益率：-11.61%

市淨率：26.96

市盈率(LYR):-112.93

市銷率: - -

資料載入中...

總覽公司新聞公告

銀諾醫藥-B: 依蘇帕格魯肽α澳門獲批上市

中國資產全面爆發！港股打新最高漲近300%

老虎资讯综合

港股IPO週報：港股18A打新浪潮迴歸！中慧生物-B、銀諾醫藥-B上市首日大漲

減肥藥賽道大火，成都這家藥企淨利潤同比增超300%，股價實現翻倍

红星资本局

紮根張江藥谷10年，銀諾醫藥成功登陸港交所

毛利率近九成的減肥神藥踏上資本旅途，銀諾醫藥高開近三倍爆燃港股

光大控股（165.HK）投資項目“銀諾醫藥”成功登陸港交所

中金資本旗下基金直投項目——銀諾醫藥於港交所上市

中金资本CICCca...

65歲教授賣減肥藥，IPO了！CFO履歷亮眼！

派格生物VS銀諾醫藥：誰會成為港股千億減肥藥企？

港股綜述 | 銀諾醫藥首日暴漲206%！英諾賽科逆勢大漲17%；“牛市旗手”爆發，中信建投漲近11%

老虎资讯综合

資本也愛GLP-1，認購比蜜雪冰城還火爆！銀諾醫藥敲鐘港股，盤中暴漲近300%

中信證券保薦生物科技領先公司銀諾醫藥成功登陸港交所

中信证券发布

公司研究室IPO週報：銀諾醫藥港股上市大漲帶動創新藥板塊；機器人熱門股臥龍電驅遞表港交所

公司研究室

*ST蘇吳股價低於1元；銀諾醫藥暗盤漲超260%

21世纪经济报道

開盤暴漲285%！國產 “減肥神藥” 今日赴港上市

生物药大时代

“國產司美格魯肽”，剛剛IPO了

市场投研资讯

招銀國際作為聯席賬簿管理人助力銀諾醫藥IPO成功發行並在香港聯交所主板掛牌上市

港股異動 | 港股減肥藥迎爆點銀諾醫藥-B(02591.HK)首掛暴漲引領派格生物醫藥-B(02565.HK)漲超40% 公司核心品種PB-119商業化在即

異動解讀 | 銀諾醫藥-B首日掛牌暴漲288.65%，GLP-1賽道引爆投資熱情

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02591/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02591","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","market":"HK","secType":"STK","nameCN":"銀諾醫藥－Ｂ","latestPrice":51.3,"timestamp":1756186963987,"preClose":52.6,"halted":0,"volume":416600,"delay":0,"floatShares":420285370,"shares":456819349,"eps":-0.4542803413994238,"marketStatus":"交易中","change":-1.3,"latestTime":"08-26 13:43:19","open":51.5,"high":51.7,"low":50.75,"amount":21312890,"amplitude":0.018061,"askPrice":51.3,"askSize":3400,"bidPrice":51.25,"bidSize":1400,"shortable":0,"etf":0,"ttmEps":-0.4542803413994238,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1756195800000},"marketStatusCode":2,"adr":0,"listingDate":1755187200000,"exchange":"SEHK","adjPreClose":52.6,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":0.716998,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","floatShares":420285370,"roa":"-11.61%","roe":"-23.27%","lyrEps":-0.45428,"volumeRatio":0.716998,"shares":456819349,"dividePrice":0,"high":51.7,"amplitude":0.018061,"preClose":52.6,"low":50.75,"week52Low":49.5,"pbRate":"26.96","week52High":74,"institutionHeld":0,"latestPrice":51.3,"committee":-0.416667,"eps":-0.4542803413994238,"divideRate":0,"volume":416600,"delay":0,"ttmEps":-0.4542803413994238,"open":51.5,"prevYearClose":18.68,"prevWeekClose":53,"prevMonthClose":18.68,"prevQuarterClose":18.68,"fiveDayClose":53.85,"twentyDayClose":18.68,"sixtyDayClose":18.68,"earningDate":1756396800000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02591\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02591\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02591\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02591\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02591","date":"2025-08-25","current":-125.916102,"percent":1,"low":-137.156472,"twenty":-128.950158,"median":-127.373977,"eighty":-126.160281,"high":-125.916102,"avg":-128.525452,"sd":3.683387,"marketCap":24028697757},"quantilePoints":[{"date":"2025-08-15","current":-137.156472,"twenty":-137.156472,"median":-137.156472,"eighty":-137.156472,"marketCap":26152907730},{"date":"2025-08-22","current":-127.373977,"twenty":-129.344203,"median":-127.373977,"eighty":-126.417438,"marketCap":24211425497},{"date":"2025-08-25","current":-125.916102,"twenty":-128.950158,"median":-127.373977,"eighty":-126.160281,"marketCap":24028697757}],"updateTime":1756184391268},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02591\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2562294121","title":"銀諾醫藥-B: 依蘇帕格魯肽α澳門獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2562294121","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562294121?lang=zh_tw&edition=fundamental","pubTime":"2025-08-25 11:08","pubTimestamp":1756091310,"startTime":"0","endTime":"0","summary":"金吾财讯 | 银诺医药 宣布，依苏帕格鲁肽α于2025年6月30日获得澳门药监局批准。公司表示此次获批是依苏帕格鲁肽α海外商业化的重要一步，未来银诺医药将持续加速全球布局，为更多患者提供创新治疗方案。同时，依苏帕格鲁肽α是在获批上市时即被明确允许无须剂量递增(0梯度)、可直接采用足量起始给药方案的长效GLP-1受体激动剂。2025年1月26日，公司自主研发的国家一类创新药——依苏帕格鲁肽α正式获得中国国家药监局批准上市。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/NzE2MmQxNjEyNzIzMzUyNjY5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NzE2MmQxNjEyNzIzMzUyNjY5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1964725","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":1},{"id":"1141757368","title":"中國資產全面爆發！港股打新最高漲近300%","url":"https://stock-news.laohu8.com/highlight/detail?id=1141757368","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141757368?lang=zh_tw&edition=fundamental","pubTime":"2025-08-19 11:05","pubTimestamp":1755572712,"startTime":"0","endTime":"0","summary":"8月19日，中国资产全面爆发，A股沪指创近10年新高！港股IPO持续势如破竹，7月以来上市12支，首日10支收涨，2支收跌，胜率高达83.33%！累计一手收益可达15,367港元。📢 双登股份（06960）正在火热申购中🔥🚩 申购方式：【老虎国际App】-【持仓】-【IPO】✨ 老虎打新优势：✅ 现金申购0手续费，融资申购0孖展利息✅ 10倍杠杆，额度充足✅ 支持暗盘交易，快人一步抢占先机✅ TOP科技券商，安全可靠","market":"hk","thumbnail":"https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"中国资产全面爆发！港股打新最高涨近300%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887","02627","06960","02591"],"gpt_icon":0},{"id":"2560924481","title":"港股IPO週報：港股18A打新浪潮迴歸！中慧生物-B、銀諾醫藥-B上市首日大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2560924481","media":"活报告","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560924481?lang=zh_tw&edition=fundamental","pubTime":"2025-08-17 17:00","pubTimestamp":1755421200,"startTime":"0","endTime":"0","summary":"最近一周，两家18A中慧生物-B、银诺医药-B正式上市，首日表现相当亮眼，分别涨157.98%、206.48%，今年港股18A生物科技公司IPO赚钱效应显著，打新热潮强势回归。中慧生物-B上市首日股价大幅高开156%，早盘一度冲高至170%，而后持续于高位震荡，最终收盘涨157.98%，全天成交近900万股，成交额约2.98亿港元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/cj/2025-08-17/doc-infmhrpc0843581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02627","HSTECH","YANG","HSCEI","BK4614","02591"],"gpt_icon":1},{"id":"2559928893","title":"減肥藥賽道大火，成都這家藥企淨利潤同比增超300%，股價實現翻倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2559928893","media":"红星资本局","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559928893?lang=zh_tw&edition=fundamental","pubTime":"2025-08-16 17:54","pubTimestamp":1755338054,"startTime":"0","endTime":"0","summary":"微成都报道本周，资本市场目光再次聚焦到减肥药赛道，港股和A股的相关板块成为市场关注的中心。今年以来，港股、A股相关概念股轮番爆发。8月15日，港股市场“减肥药新贵”银诺医药（02591.HK）上市首日暴涨，市值突破260亿港元，成为2025年最火爆的IPO之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202508163486040338.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0965509010.AUD","LU0208291251.USD","LU1061106388.HKD","LU1941712264.USD","BK4588","LU0238689110.USD","IE00B1BXHZ80.USD","LU1066051498.USD","LU1934455194.USD","LU1037948541.HKD","LU1571399168.USD","02591","LU0211331839.USD","LU0320765646.SGD","LU1066051811.HKD","LU1917777945.USD","MRK","LU1929549753.HKD","LU2112291526.USD","LU2361044949.HKD","SG9999015341.SGD","BK4007","SG9999014542.SGD","LU0861579265.USD","LU1162221912.USD","LU0203345920.USD","LU1069347547.HKD","LU1989772840.SGD","BK4559","LU0122379950.USD","LU0965509283.SGD","SG9999001176.SGD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IE00BN8TJ469.HKD","LU0320765489.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU2324357040.USD","LU1023059063.AUD","LU0058720904.USD","LU1430594728.SGD","SG9999015358.SGD","LU0965509101.SGD","SG9999014559.SGD","LU1037948897.HKD","BK4516","LU2023250843.SGD","SGXZ57979304.SGD","LU0006306889.USD"],"gpt_icon":1},{"id":"2559917948","title":"紮根張江藥谷10年，銀諾醫藥成功登陸港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2559917948","media":"你好张江","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559917948?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 20:49","pubTimestamp":1755262196,"startTime":"0","endTime":"0","summary":"8月15日，银诺医药成功在香港联合交易所主板挂牌上市。2025年1月26日，银诺医药自主研发的首个国家1类创新药依苏帕格鲁肽α（怡诺轻）被国家药品监督管理局批准上市，用于治疗成人2型糖尿病。从张江实验室到港交所上市，凭借创新的产品管线、卓越的研发实力及全球化商业布局，银诺医药正稳步崛起为代谢性疾病治疗领域的领军企业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815213100a6e864c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815213100a6e864c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591"],"gpt_icon":1},{"id":"2559911998","title":"毛利率近九成的減肥神藥踏上資本旅途，銀諾醫藥高開近三倍爆燃港股","url":"https://stock-news.laohu8.com/highlight/detail?id=2559911998","media":"星岛财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559911998?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 19:18","pubTimestamp":1755256717,"startTime":"0","endTime":"0","summary":"上市前夕，银诺医药暗盘暴涨超270%，股价最高71.45港元/股，总市值超310亿港元。但资本市场光环之外，银诺医药可谓前有强敌后有追兵。昆药集团出资0.83亿元持股51%，王庆华主要以转让知识产权的形式出资持有49%股权。2020年，昆药集团将股权转让，随后银诺医药由王庆华带领继续独立发展。银诺医药管线情况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815201307a6e84540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815201307a6e84540&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591","YANG","BK4614"],"gpt_icon":1},{"id":"2559991187","title":"光大控股（165.HK）投資項目“銀諾醫藥”成功登陸港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2559991187","media":"新浪财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559991187?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 19:08","pubTimestamp":1755256101,"startTime":"0","endTime":"0","summary":"来源：市场资讯 2025年8月15日，光大控股旗下光控泰州基金投资企业——广州银诺医药集团股份有限公司成功在香港联合证券交易所挂牌上市，股票代码为2591.HK。该项目于2021年12月完成投资，是光大控股在医疗健康板块的重要布局之一。光控泰州基金由光大控股和泰州医药高新区联合发起，由光大控股母基金团队管理，包括直投基金和母基金，总规模10亿元，于2020年2月份备案成立。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081519113794e57ec2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081519113794e57ec2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591"],"gpt_icon":1},{"id":"2559723914","title":"中金資本旗下基金直投項目——銀諾醫藥於港交所上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2559723914","media":"中金资本CICCca...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559723914?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 18:20","pubTimestamp":1755253243,"startTime":"0","endTime":"0","summary":"2025年8月15日，专注于糖尿病及其他代谢性疾病创新疗法的生物医药企业——广州银诺医药集团股份有限公司正式登陆港交所，此次IPO发行价为每股18.68港元。中金资本旗下基金于2021年参与了银诺医药A轮融资。中金公司担任本次项目的联席保荐人、整体协调人、联席全球协调人及联席账簿管理人。银诺医药目前拥有多项针对糖尿病、肥胖和非酒精性脂肪性肝炎等适应症的创新药物研发管线，具备全球知识产权，覆盖全球研发与市场布局。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815210744a6e85a72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815210744a6e85a72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591"],"gpt_icon":1},{"id":"2559919569","title":"65歲教授賣減肥藥，IPO了！CFO履歷亮眼！","url":"https://stock-news.laohu8.com/highlight/detail?id=2559919569","media":"财能无界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559919569?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 18:02","pubTimestamp":1755252172,"startTime":"0","endTime":"0","summary":"港交所又迎来一款“减肥神药”！银诺医药的掌舵人是现年65岁的王庆华。该产品于2025年1月获得国家药品监督管理局批准上市，目前已在医院、药店及电商平台等渠道销售。目前，治疗肥胖超重的依苏帕格鲁肽α已在中国完成IIa期临床试验，并于2025年3月启动IIb/III期临床试验，公司称预计2026年第四季度完成。自2009年3月至2015年6月，她担任上海北岸信息技术有限公司部门经理。招股书显示，姜帆女士2024年薪酬共计 770.5 万元，2023年薪酬共计 1043.9 万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815184054a6e81c6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815184054a6e81c6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591"],"gpt_icon":1},{"id":"2559915284","title":"派格生物VS銀諾醫藥：誰會成為港股千億減肥藥企？","url":"https://stock-news.laohu8.com/highlight/detail?id=2559915284","media":"臻研厂","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559915284?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 17:05","pubTimestamp":1755248747,"startTime":"0","endTime":"0","summary":"资料来源：东方财富PART.1派格生物VS银诺医药：减肥药领域双雄争锋银诺医药成立于2014年，是亚洲第一家及全球第三家商业化原研人源长效胰高血糖素样肽-1受体激动剂的公司。并且，银诺医药的依苏帕格鲁肽α在肥胖适应症方面进展缓慢，临床试验预计要到2026年第四季度才能完成。总的来说，从研发管线深度和广度、市值安全边际及未来增长潜力综合判断，派格医药比银诺医药更有性价比。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815180034a6e80852&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815180034a6e80852&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4614","VS","02591","BK4085","YANG"],"gpt_icon":1},{"id":"1133019434","title":"港股綜述 | 銀諾醫藥首日暴漲206%！英諾賽科逆勢大漲17%；“牛市旗手”爆發，中信建投漲近11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133019434","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133019434?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 16:41","pubTimestamp":1755247274,"startTime":"0","endTime":"0","summary":"基石药业-B涨超24%，上半年研发支出增超58%，下半年有望获得授权费收入。$九源基因$涨23%，将于下周一发布业绩，预计年内向巴西等递交司美格鲁肽新药申请。$老铺黄金$涨超3%，老铺黄金宣布将于8月25日进行产品提价调整。A股行情A股三大指数低开高走，截至收盘，沪指涨0.83%，深成指涨1.6%，创业板指涨2.61%。另外，银行股逆市下跌，$中国银行$、$民生银行$、$光大银行$等多股跌逾2%。","market":"us","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSCEI","601066","HSTECH","BK0276","BK4614","02577","BK1163","02591","YANG","07226"],"gpt_icon":1},{"id":"2559913262","title":"資本也愛GLP-1，認購比蜜雪冰城還火爆！銀諾醫藥敲鐘港股，盤中暴漲近300%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559913262","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559913262?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 16:32","pubTimestamp":1755246775,"startTime":"0","endTime":"0","summary":"8月15日，本土GLP-1药企银诺医药-B正式在港股敲钟，发行价为18.68港元/股。2024年年底，银诺医药首次向港交所主板提交上市申请书。趁着GLP-1减肥药的“东风”，叠加港股创新药板块回暖，银诺医药新股认购异常火爆。截至目前，银诺医药已有一款GLP-1一类创新药上市。在今年618期间，怡诺轻在京东、阿里分别取得了内分泌用药第七名和GLP-1药物第三名的成绩。业绩方面，银诺医药在2023年和2024年年内分别亏损7.33亿元、1.75亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815163750a6e7de7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815163750a6e7de7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4614","GLP","BK4590","YANG","BK4144","02591"],"gpt_icon":1},{"id":"2559997466","title":"中信證券保薦生物科技領先公司銀諾醫藥成功登陸港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2559997466","media":"中信证券发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559997466?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 15:00","pubTimestamp":1755241225,"startTime":"0","endTime":"0","summary":"2025年8月15日，广州银诺医药集团股份有限公司成功于香港联交所主板上市，发行规模约6.83亿港币。中信证券担任联席保荐人、整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人。中信证券全球投资银行管理委员会联席主任程杰、全球投资银行管理委员会委员于杨出席上市仪式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815150308a48a2fd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815150308a48a2fd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591"],"gpt_icon":1},{"id":"2559453997","title":"公司研究室IPO週報：銀諾醫藥港股上市大漲帶動創新藥板塊；機器人熱門股臥龍電驅遞表港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2559453997","media":"公司研究室","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559453997?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 14:52","pubTimestamp":1755240779,"startTime":"0","endTime":"0","summary":"IPO动态A股8月11日，科马材料在上交所主板上会，顺利过会。8月13日，军信环保、卧龙电驱向港交所递交招股书。热点追踪银诺医药港股上市大涨，带动创新药板块8月15日，银诺医药新股上市首日，股价高开285%，最高报74港元。公司此次全球发售所得款项净额约达6.1亿元。机器人热门股卧龙电驱递表港交所8月13日，卧龙电驱向港交所呈交了上市申请文件，联席保荐人为中金公司、华泰国际、广发证券（香港）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815145528a48a2c7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815145528a48a2c7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["YANG","BK4614","02591"],"gpt_icon":1},{"id":"2559996710","title":"*ST蘇吳股價低於1元；銀諾醫藥暗盤漲超260%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559996710","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559996710?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 10:24","pubTimestamp":1755224649,"startTime":"0","endTime":"0","summary":"今年1月至6月，黔南州特殊困难群众住院发生医疗总费用2.82亿元，三重医疗保障报销达2.44亿元。2024年同期营业收入约2.93亿元；归属于上市公司股东的净利润亏损约528万元；基本每股收益亏损0.02元。港股新股银诺医药-B暗盘涨超260%8月14日，港股新股银诺医药-B暗盘涨超260%，报68.5港元。舆情预警*ST苏吴：公司股票可能因股价低于1元而终止上市8月14日，*ST苏吴公告称，公司股票2025年8月14日收盘价为0.99元/股，首次低于人民币1元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815102654a489b459&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815102654a489b459&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591"],"gpt_icon":1},{"id":"2559999233","title":"開盤暴漲285%！國產 “減肥神藥” 今日赴港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2559999233","media":"生物药大时代","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559999233?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 10:21","pubTimestamp":1755224491,"startTime":"0","endTime":"0","summary":"8月15日，专注于糖尿病和其他代谢性疾病创新疗法的生物制药公司银诺医药成功在港交所主板上市，中信证券、中金公司为联席保荐人。因为其核心产品也能用于治疗超重和肥胖，因而也具有国产“减肥神药”概念，获得市场热捧。截至2025年5月31日止五个月，在中国销售依苏帕格鲁肽α取得入3814万人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815102639a489b438&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815102639a489b438&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AD","02591"],"gpt_icon":1},{"id":"2559916389","title":"“國產司美格魯肽”，剛剛IPO了","url":"https://stock-news.laohu8.com/highlight/detail?id=2559916389","media":"市场投研资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559916389?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 10:15","pubTimestamp":1755224100,"startTime":"0","endTime":"0","summary":"由于其减肥适应症尚在Ⅱb/Ⅲ期临床试验阶段，所以银诺也被称为“国产司美格鲁肽”概念股。在全球层面，诺和诺德、礼来双巨头垄断90%减重药市场，司美格鲁肽年销售292亿美元。在中国战场，在市面10余款上市GLP-1药物中，国产份额仅6.4%。2020年10月，昆药集团减持套现1.66亿元并退出了股东行列。此次成功上市，银诺将获得更稳定的资金供给。银诺表示，此次IPO募资金额将拟投向三大方向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-08-15/doc-infkznmp3132807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02591"],"gpt_icon":1},{"id":"2559915549","title":"招銀國際作為聯席賬簿管理人助力銀諾醫藥IPO成功發行並在香港聯交所主板掛牌上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2559915549","media":"招银国际","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559915549?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 09:52","pubTimestamp":1755222742,"startTime":"0","endTime":"0","summary":"交易概述2025年8月15日，广州银诺医药集团股份有限公司成功在香港联合交易所主板挂牌上市。招银国际担任银诺医药在香港IPO的联席账簿管理人及联席牵头经办人。招银国际融资已逐步成为香港资本市场最为活跃且增长力强劲的金融机构之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081510092694e4a30c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081510092694e4a30c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591"],"gpt_icon":1},{"id":"2559995124","title":"港股異動 | 港股減肥藥迎爆點 銀諾醫藥-B(02591.HK)首掛暴漲引領 派格生物醫藥-B(02565.HK)漲超40% 公司核心品種PB-119商業化在即","url":"https://stock-news.laohu8.com/highlight/detail?id=2559995124","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559995124?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 09:39","pubTimestamp":1755221971,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["07226","BK1161","BK4614","161726","HSCEI","399441","PB","YANG","02565","BK4211","02591"],"gpt_icon":0},{"id":"1141938292","title":"異動解讀 | 銀諾醫藥-B首日掛牌暴漲288.65%，GLP-1賽道引爆投資熱情","url":"https://stock-news.laohu8.com/highlight/detail?id=1141938292","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141938292?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 09:33","pubTimestamp":1755221609,"startTime":"0","endTime":"0","summary":"8月15日（周五）上午，专注于代谢性疾病治疗的银诺医药-B在港交所主板挂牌上市，盘中股价大涨288.65%，引发市场广泛关注。这一亮眼表现凸显了投资者对GLP-1受体激动剂赛道的热烈追捧。银诺医药此前公布的招股结果显示，公司全球发售3655.64万股股份，最终发售价定为每股18.68港元，募集资金净额约6.35亿港元。银诺医药作为该领域的先行者之一，其产品优势和市场潜力获得投资者认可，推动股价在首日交易中大幅上涨。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02591"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":54,"code":"91000000","status":"200"}]}}